» Articles » PMID: 27492541

Identification of Five Clusters of Comorbidities in a Longitudinal Japanese Chronic Obstructive Pulmonary Disease Cohort

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2016 Aug 6
PMID 27492541
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from various comorbidities. Recently, cluster analysis has been proposed to examine the phenotypic heterogeneity in COPD. In order to comprehensively understand the comorbidities of COPD in Japan, we conducted multicenter, longitudinal cohort study, called the Keio COPD Comorbidity Research (K-CCR). In this cohort, comorbid diagnoses were established by both objective examination and review of clinical records, in addition to self-report. We aimed to investigate the clustering of nineteen clinically relevant comorbidities and the meaningful outcomes of the clusters over a two-year follow-up period.

Material And Methods: The present study analyzed data from COPD patients whose data of comorbidities were completed (n = 311). Cluster analysis was performed using Ward's minimum-variance method.

Results: Five comorbidity clusters were identified: less comorbidity; malignancy; metabolic and cardiovascular; gastroesophageal reflux disease (GERD) and psychological; and underweight and anemic. FEV1 did not differ among the clusters. GERD and psychological cluster had worse COPD assessment test (CAT) and Saint George's respiratory questionnaire (SGRQ) at baseline compared to the other clusters (CAT: p = 0.0003 and SGRQ: p = 0.00046). The rate of change in these scores did not differ within 2 years. The underweight and anemic cluster included subjects with lower baseline ratio of predicted diffusing capacity (DLco/VA) compared to the malignancy cluster (p = 0.036).

Conclusions: Five clusters of comorbidities were identified in Japanese COPD patients. The clinical characteristics and health-related quality of life were different among these clusters during a follow-up of two years.

Citing Articles

Study protocol: pneumonia and inhaled corticosteroid treatment patterns in chronic obstructive pulmonary disease - a cohort study using sequence analysis (PICCS).

Klitgaard A, Ibsen R, Hilberg O, Lokke A BMJ Open. 2023; 13(6):e072685.

PMID: 37263696 PMC: 10254891. DOI: 10.1136/bmjopen-2023-072685.


Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Zhao G, Li X, Lei S, Zhao H, Zhang H, Li J Front Oncol. 2022; 12:947981.

PMID: 36185264 PMC: 9523743. DOI: 10.3389/fonc.2022.947981.


Health Priorities in Chronic Obstructive Pulmonary Disease Patients with Multimorbidity: A Qualitative Study.

Cai M, Cui M, Nong Y, Qin J, Mo S Patient Prefer Adherence. 2022; 16:2521-2531.

PMID: 36124126 PMC: 9482456. DOI: 10.2147/PPA.S377832.


Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study.

Yamada H, Matsumoto I, Makita N, Arita Y, Hayashi N, Mitsuoka K Respir Res. 2022; 23(1):255.

PMID: 36123707 PMC: 9487074. DOI: 10.1186/s12931-022-02184-6.


Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) Comorbidities in Lithuanian National Database: A Cluster Analysis.

Jureviciene E, Burneikaite G, Dambrauskas L, Kasiulevicius V, Kazenaite E, Navickas R Int J Environ Res Public Health. 2022; 19(2).

PMID: 35055792 PMC: 8775709. DOI: 10.3390/ijerph19020970.